Foresite Capital Management II’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $29.2M | Hold |
|
|||||
|
2023
Q2 | $39.6M | Hold |
|
|||||
|
2023
Q1 | $39.5M | Sell |
|
|||||
|
2022
Q4 | $49.5M | Sell |
|
|||||
|
2022
Q3 | $49.9M | Hold |
|
|||||
|
2022
Q2 | $79.3M | Hold |
|
|||||
|
2022
Q1 | $133M | Hold |
|
|||||
|
2021
Q4 | $261M | Hold |
|
|||||
|
2021
Q3 | $255M | Hold |
|
|||||
|
2021
Q2 | $343M | Sell |
|
|||||
|
2021
Q1 | $408M | Sell |
|
|||||
|
2020
Q4 | $355M | Sell |
|
|||||
|
2020
Q3 | $437M | Sell |
|
|||||
|
2020
Q2 | $492M | Sell |
|
|||||
|
2020
Q1 | $411M | Sell |
|
|||||
|
2019
Q4 | $521M | Hold |
|
|||||
|
2019
Q3 | $345M | Buy |
|